Cargando…
Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer
Small cell lung cancer (SCLC) is a devastating neuroendocrine carcinoma. MYCL (L-Myc) is frequently amplified in human SCLC, but its roles in SCLC progression are poorly understood. We isolated preneoplastic neuroendocrine cells from a mouse model of SCLC and found that ectopic expression of L-Myc,...
Autores principales: | Kim, Dong-Wook, Wu, Nan, Kim, Young-Chul, Cheng, Pei Feng, Basom, Ryan, Kim, Dongkyoon, Dunn, Colin T., Lee, Anastasia Y., Kim, Keebeom, Lee, Chang Sup, Singh, Andrew, Gazdar, Adi F., Harris, Chris R., Eisenman, Robert N., Park, Kwon-Sik, MacPherson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911928/ https://www.ncbi.nlm.nih.gov/pubmed/27298335 http://dx.doi.org/10.1101/gad.279307.116 |
Ejemplares similares
-
The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells
por: Anderson, David A., et al.
Publicado: (2020) -
MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
por: Fong, K. M., et al.
Publicado: (1996) -
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
por: Cheng, Jingwei, et al.
Publicado: (2017) -
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL
por: Suzuki, Kazuhito, et al.
Publicado: (2016) -
MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway
por: Jiang, Hongnan, et al.
Publicado: (2022)